Iran’s Medicine Cabinet Runs Empty as Economic Crisis Deepens Healthcare Collapse

A woman in Tehran waits for her father’s three heart medications to be filled. The pharmacy charges 8.5 million rials^[1] – roughly $200 at black-market exchange rates. She can afford only three pills, leaving the rest unfilled. Her father goes without.^[1]

This is not a rare story. Across Iran, personal accounts collected by Iran International reveal a healthcare system collapsing under the weight of currency devaluation, sanctions-driven shortages, and a government unable or unwilling to stabilize pharmaceutical supply chains.^[1] The pattern is consistent: essential drugs disappear from official pharmacies while thriving on the black market, forcing ordinary Iranians into impossible choices between treatment and solvency.

The scope of the shortage extends beyond heart medications. Insulin for diabetics is “hard to find,” according to reported accounts.^[1] Fluoxetine, a basic antidepressant, vanishes from pharmacy shelves – when available, it’s often imported at prices far beyond reach.^[1] Codeine and clonazepam, simple domestic-produced painkillers and sedatives, grow scarce in official channels even as they flood underground markets.^[1] A design student seeking a sewing machine – a basic tool for her trade – cannot find a quality model for less than 150 million rials, roughly $3,600.^[1]

The human arithmetic is brutal. One person reported taking a 1 billion rial loan (approximately $24,000) to cover colon cancer treatment, only to discover afterward that the government had reclassified their poverty status, cutting them off from subsidies and welfare support.^[1] A cancer patient requiring bone marrow transplant faces a 25-30 million rial bill – money they simply do not have.^[1] Those managing chronic illnesses must maintain constant cash reserves of at least 200 million rials to cover emergency hospitalization, a sum representing years of savings for most Iranians.^[1]

The regime’s pharmaceutical crisis reflects deeper economic fractures. Medicine costs have tripled in six months,^[2] driven by rial collapse and import restrictions. Pensions remain unpaid, forcing retirees to choose between medications and rent.^[2] The government’s official pricing cannot compete with black-market supply chains, which move drugs more efficiently than state distribution networks – a perverse outcome of central planning meeting currency crisis.

What emerges from these accounts is not simply a supply problem but a legitimacy problem. The regime frames itself as a welfare state protecting citizens from capitalist exploitation, yet ordinary Iranians now experience the healthcare system as a mechanism of extraction – one that demands they impoverish themselves for survival. A retiree receiving 18 million rials monthly (roughly $430) classified as the ninth decile of poverty describes the government’s wealth classification as “baseless,” noting she owns no home, no car, no independent income.^[1]

This healthcare breakdown also reveals how sanctions and internal mismanagement interact. Foreign currency shortages make imported drugs unaffordable. Domestic pharmaceutical production, meanwhile, faces raw material import restrictions and currency instability that makes manufacturing economics nonviable at official prices. The result: a two-tier system where the wealthy access black-market drugs at inflated prices, while the poor wait for medications that never arrive in pharmacies.

The regime has escalated executions to 2,003 over the past year,^[3] using capital punishment as a tool to suppress dissent and maintain control through fear. Yet it cannot supply insulin to diabetics or pain medication to cancer patients. This contradiction – overwhelming state violence paired with inability to deliver basic services – defines Iran’s current stability calculus. Regimes can survive external pressure and even internal protest. They struggle when they cannot convince citizens they are worth obeying because the state cannot perform its most basic function: keeping people alive.

What this tells us about the regime’s stability calculus: the Islamic Republic faces not a single crisis but cascading failures in different domains. The IRGC remains powerful enough to execute thousands. The currency has collapsed enough that basic medicines are unaffordable. The black market is organized enough to distribute contraband pharmaceuticals efficiently. But the state cannot reconcile these contradictions – it cannot simultaneously maintain security apparatus dominance, stabilize the currency, and ensure pharmaceutical access. Iranians are not choosing between the regime and revolution. They are simply choosing survival, and the regime is making that choice increasingly incompatible with loyalty.